Related Experiment Videos
[Perianal basal cell carcinoma].
L Montagliani1, P Aubert, B Vergeau
1Service de chirurgie viscérale, HIA Begin, Saint-Mandé.
Presse Medicale (Paris, France : 1983)
|April 24, 2004
Summary
Perianal basal cell carcinoma is rare but treatable with local tumor removal. Close follow-up is essential due to potential for local recurrence, ensuring good prognosis for this skin cancer.
Area of Science:
- Dermatology
- Oncology
- Surgical Pathology
Background:
- Basal cell carcinoma (BCC) rarely occurs in the perianal region.
- Understanding the long-term behavior and treatment options for perianal BCC is crucial.
Observation:
- A 66-year-old male presented with a non-healing, hemorrhagic anal lesion.
- The lesion, present for 5 years, was initially misdiagnosed as hemorrhoidal thrombosis.
- Biopsy confirmed an ulcerous-nodular basal cell carcinoma at the anal-cutaneous junction.
Findings:
- Perianal basal cell carcinoma is an uncommon diagnosis.
- Surgical excision is the primary treatment modality for perianal BCC.
- The condition generally has a favorable prognosis.
Implications:
- Local tumor excision is the standard treatment for perianal basal cell carcinoma.
- Despite a good prognosis, vigilant monitoring is necessary to detect potential local recurrences.
- Early diagnosis and management are key for successful outcomes in rare BCC presentations.